ReP USP - Resultado da busca

Artigo de periodico
Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations (2024)
Ponnaiah, Maharajah; Zakiev, Emile; Lhomme, Marie; Rached, Fabiana; Camont, Laurent; Serrano Junior, Carlos Vicente ; Santos Filho, Raul Dias dos ; Chapman, M. John; Orekhov, Alexander; Kontush, Anatol
Fonte: ATHEROSCLEROSIS PLUS. Unidade: FM
Assuntos: LIPOPROTEÍNAS LDL, INFARTO DO MIOCÁRDIO, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONNAIAH, Maharajah et al. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations. ATHEROSCLEROSIS PLUS, v. 55, p. 21-30, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58815. Acesso em: 07 nov. 2024.
APA
Ponnaiah, M., Zakiev, E., Lhomme, M., Rached, F., Camont, L., Serrano Junior, C. V., et al. (2024). Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations. ATHEROSCLEROSIS PLUS, 55, 21-30. doi:10.1016/j.athplu.2023.12.001
NLM
Ponnaiah M, Zakiev E, Lhomme M, Rached F, Camont L, Serrano Junior CV, Santos Filho RD dos, Chapman MJ, Orekhov A, Kontush A. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations [Internet]. ATHEROSCLEROSIS PLUS. 2024 ; 55 21-30.[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58815
Vancouver
Ponnaiah M, Zakiev E, Lhomme M, Rached F, Camont L, Serrano Junior CV, Santos Filho RD dos, Chapman MJ, Orekhov A, Kontush A. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations [Internet]. ATHEROSCLEROSIS PLUS. 2024 ; 55 21-30.[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58815
Artigo de periodico
Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project (2022)
Sajatovic, Martha; Dols, Annemiek; Rej, Soham; Almeida, Osvaldo P; Beunders, Alexandra J. M; Blumberg, Hilary P; Briggs, Farren B. S; Forester, Brent P; Patrick, Regan E; Forlenza, Orestes Vicente
Fonte: Bipolar disorders. Unidade: FM
Assuntos: TRANSTORNO BIPOLAR, COMPORTAMENTO, COMORBIDADE, DEPRESSÃO, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAJATOVIC, Martha et al. Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project. Bipolar disorders, v. 24, n. 2, p. 195-206, 2022Tradução . . Disponível em: https://doi.org/10.1111/bdi.13119. Acesso em: 07 nov. 2024.
APA
Sajatovic, M., Dols, A., Rej, S., Almeida, O. P., Beunders, A. J. M., Blumberg, H. P., et al. (2022). Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project. Bipolar disorders, 24( 2), 195-206. doi:10.1111/bdi.13119
NLM
Sajatovic M, Dols A, Rej S, Almeida OP, Beunders AJM, Blumberg HP, Briggs FBS, Forester BP, Patrick RE, Forlenza OV. Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project [Internet]. Bipolar disorders. 2022 ; 24( 2): 195-206.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1111/bdi.13119
Vancouver
Sajatovic M, Dols A, Rej S, Almeida OP, Beunders AJM, Blumberg HP, Briggs FBS, Forester BP, Patrick RE, Forlenza OV. Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project [Internet]. Bipolar disorders. 2022 ; 24( 2): 195-206.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1111/bdi.13119
Artigo de periodico
Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey (2022)
Drucker, Aaron M.; Lam, Megan; Flohr, Carsten; Thyssen, Jacob P.; Kabashima, Kenji; Bissonnette, Robert; Dlova, Ncoza C.; Aoki, Valeria ; Chen, Max; Yu, Joshua
Fonte: Dermatitis. Unidade: FM
Assuntos: DERMATITE, EPIDEMIOLOGIA, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRUCKER, Aaron M. et al. Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey. Dermatitis, v. 33, n. 3, p. 200-206, 2022Tradução . . Disponível em: https://doi.org/10.1097/DER.0000000000000845. Acesso em: 07 nov. 2024.
APA
Drucker, A. M., Lam, M., Flohr, C., Thyssen, J. P., Kabashima, K., Bissonnette, R., et al. (2022). Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey. Dermatitis, 33( 3), 200-206. doi:10.1097/DER.0000000000000845
NLM
Drucker AM, Lam M, Flohr C, Thyssen JP, Kabashima K, Bissonnette R, Dlova NC, Aoki V, Chen M, Yu J. Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey [Internet]. Dermatitis. 2022 ; 33( 3): 200-206.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1097/DER.0000000000000845
Vancouver
Drucker AM, Lam M, Flohr C, Thyssen JP, Kabashima K, Bissonnette R, Dlova NC, Aoki V, Chen M, Yu J. Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey [Internet]. Dermatitis. 2022 ; 33( 3): 200-206.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1097/DER.0000000000000845
Artigo de periodico
Clinical practice gaps and challenges in non-alcoholic steatohepatitis care: An international physician needs assessment (2022)
Lazure, Patrice; Tomlinson, Jeremy W.; V, Kris Kowdley; Magni, Paolo; Santos Filho, Raul Dias dos ; Jacobs, Ginny; Murray, Suzanne
Fonte: Liver international. Unidade: FM
Assuntos: FÍGADO GORDUROSO, EDUCAÇÃO PERMANENTE, PRÁTICA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAZURE, Patrice et al. Clinical practice gaps and challenges in non-alcoholic steatohepatitis care: An international physician needs assessment. Liver international, v. 42, n. 8, p. 1772-1782, 2022Tradução . . Disponível em: https://doi.org/10.1111/liv.15324. Acesso em: 07 nov. 2024.
APA
Lazure, P., Tomlinson, J. W., V, K. K., Magni, P., Santos Filho, R. D. dos, Jacobs, G., & Murray, S. (2022). Clinical practice gaps and challenges in non-alcoholic steatohepatitis care: An international physician needs assessment. Liver international, 42( 8), 1772-1782. doi:10.1111/liv.15324
NLM
Lazure P, Tomlinson JW, V KK, Magni P, Santos Filho RD dos, Jacobs G, Murray S. Clinical practice gaps and challenges in non-alcoholic steatohepatitis care: An international physician needs assessment [Internet]. Liver international. 2022 ; 42( 8): 1772-1782.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1111/liv.15324
Vancouver
Lazure P, Tomlinson JW, V KK, Magni P, Santos Filho RD dos, Jacobs G, Murray S. Clinical practice gaps and challenges in non-alcoholic steatohepatitis care: An international physician needs assessment [Internet]. Liver international. 2022 ; 42( 8): 1772-1782.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1111/liv.15324
Artigo de periodico
Brain stimulation and other biological non-pharmacological interventions in mental disorders: an umbrella review (2022)
Rosson, Stella; Filippis, Renato de; Croatto, Giovanni; Collantoni, Enrico; Pallottino, Simone; Guinart, Daniel; Brunoni, Andre Russowsky ; Dell'osso, Bernardo; Pigato, Giorgio; Hyde, Joshua
Fonte: Neuroscience and biobehavioral reviews. Unidade: FM
Assuntos: TRANSTORNOS MENTAIS, ESTIMULAÇÃO MAGNÉTICA TRANSCRANIANA, ESQUIZOFRENIA, DEPRESSÃO, METANÁLISE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSON, Stella et al. Brain stimulation and other biological non-pharmacological interventions in mental disorders: an umbrella review. Neuroscience and biobehavioral reviews, v. 139, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.neubiorev.2022.104743. Acesso em: 07 nov. 2024.
APA
Rosson, S., Filippis, R. de, Croatto, G., Collantoni, E., Pallottino, S., Guinart, D., et al. (2022). Brain stimulation and other biological non-pharmacological interventions in mental disorders: an umbrella review. Neuroscience and biobehavioral reviews, 139. doi:10.1016/j.neubiorev.2022.104743
NLM
Rosson S, Filippis R de, Croatto G, Collantoni E, Pallottino S, Guinart D, Brunoni AR, Dell'osso B, Pigato G, Hyde J. Brain stimulation and other biological non-pharmacological interventions in mental disorders: an umbrella review [Internet]. Neuroscience and biobehavioral reviews. 2022 ; 139[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.neubiorev.2022.104743
Vancouver
Rosson S, Filippis R de, Croatto G, Collantoni E, Pallottino S, Guinart D, Brunoni AR, Dell'osso B, Pigato G, Hyde J. Brain stimulation and other biological non-pharmacological interventions in mental disorders: an umbrella review [Internet]. Neuroscience and biobehavioral reviews. 2022 ; 139[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.neubiorev.2022.104743
Artigo de periodico
Metabolomics as a potential tool for the diagnosis of growth hormone deficiency (GHD): a review (2020)
San Martin, Breno Sena De ; Ferreira, Vinicius Guimarães ; Bitencourt, Mariana Rechia ; Pereira, Paulo Cesar Gonçalves ; Carrilho, Emanuel ; Assunção, Nilson Antonio de ; Carvalho, Luciani Renata Silveira de
Fonte: Archives of Endocrinology and Metabolism. Unidades: IQSC, FM
Assunto: METABOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAN MARTIN, Breno Sena De et al. Metabolomics as a potential tool for the diagnosis of growth hormone deficiency (GHD): a review. Archives of Endocrinology and Metabolism, v. 64, n. 6, p. 654-663, 2020Tradução . . Disponível em: https://doi.org/10.20945/2359-3997000000300. Acesso em: 07 nov. 2024.
APA
San Martin, B. S. D., Ferreira, V. G., Bitencourt, M. R., Pereira, P. C. G., Carrilho, E., Assunção, N. A. de, & Carvalho, L. R. S. de. (2020). Metabolomics as a potential tool for the diagnosis of growth hormone deficiency (GHD): a review. Archives of Endocrinology and Metabolism, 64( 6), 654-663. doi:10.20945/2359-3997000000300
NLM
San Martin BSD, Ferreira VG, Bitencourt MR, Pereira PCG, Carrilho E, Assunção NA de, Carvalho LRS de. Metabolomics as a potential tool for the diagnosis of growth hormone deficiency (GHD): a review [Internet]. Archives of Endocrinology and Metabolism. 2020 ; 64( 6): 654-663.[citado 2024 nov. 07 ] Available from: https://doi.org/10.20945/2359-3997000000300
Vancouver
San Martin BSD, Ferreira VG, Bitencourt MR, Pereira PCG, Carrilho E, Assunção NA de, Carvalho LRS de. Metabolomics as a potential tool for the diagnosis of growth hormone deficiency (GHD): a review [Internet]. Archives of Endocrinology and Metabolism. 2020 ; 64( 6): 654-663.[citado 2024 nov. 07 ] Available from: https://doi.org/10.20945/2359-3997000000300
Artigo de periodico
Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes (2018)
Everett, Brendan M.; Nicolau, Jose C.; DONATH, Marc Y.; PRADHAN, Aruna D.; THUREN, Tom; PAIS, Prem; GLYNN, Robert J; LIBBY, Peter; RIDKER, Paul M.
Fonte: Journal of the american college of cardiology. Unidade: FM
Assuntos: ANTI-INFLAMATÓRIOS, DOENÇAS CARDIOVASCULARES, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EVERETT, Brendan M. et al. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. Journal of the american college of cardiology, v. 71, n. 21, p. 2392-2401, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.03.002. Acesso em: 07 nov. 2024.
APA
Everett, B. M., Nicolau, J. C., DONATH, M. Y., PRADHAN, A. D., THUREN, T., PAIS, P., et al. (2018). Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. Journal of the american college of cardiology, 71( 21), 2392-2401. doi:10.1016/j.jacc.2018.03.002
NLM
Everett BM, Nicolau JC, DONATH MY, PRADHAN AD, THUREN T, PAIS P, GLYNN RJ, LIBBY P, RIDKER PM. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes [Internet]. Journal of the american college of cardiology. 2018 ; 71( 21): 2392-2401.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.jacc.2018.03.002
Vancouver
Everett BM, Nicolau JC, DONATH MY, PRADHAN AD, THUREN T, PAIS P, GLYNN RJ, LIBBY P, RIDKER PM. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes [Internet]. Journal of the american college of cardiology. 2018 ; 71( 21): 2392-2401.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.jacc.2018.03.002
Artigo de periodico
Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era (2018)
Fernandes, Caio Julio Cesar; Souza, Rogerio; PILOTO, Bruna; CASTRO, Marcela; OLEAS, Francisca Gavilanes; ALVES JR., Jose Leonidas; PRADA, Luis Felipe Lopes; JARDIM, Carlos
Fonte: European respiratory journal. Unidade: FM
Assuntos: ESQUISTOSSOMOSE, HIPERTENSÃO PULMONAR, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Caio Julio Cesar et al. Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era. European respiratory journal, v. 51, n. 6, 2018Tradução . . Disponível em: https://doi.org/10.1183/13993003.00307-2018. Acesso em: 07 nov. 2024.
APA
Fernandes, C. J. C., Souza, R., PILOTO, B., CASTRO, M., OLEAS, F. G., ALVES JR., J. L., et al. (2018). Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era. European respiratory journal, 51( 6). doi:10.1183/13993003.00307-2018
NLM
Fernandes CJC, Souza R, PILOTO B, CASTRO M, OLEAS FG, ALVES JR. JL, PRADA LFL, JARDIM C. Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era [Internet]. European respiratory journal. 2018 ; 51( 6):[citado 2024 nov. 07 ] Available from: https://doi.org/10.1183/13993003.00307-2018
Vancouver
Fernandes CJC, Souza R, PILOTO B, CASTRO M, OLEAS FG, ALVES JR. JL, PRADA LFL, JARDIM C. Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era [Internet]. European respiratory journal. 2018 ; 51( 6):[citado 2024 nov. 07 ] Available from: https://doi.org/10.1183/13993003.00307-2018
Artigo de periodico
Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial (2018)
Corbalan, Ramon; Nicolau, Jose Carlos
Fonte: Journal of the american college of cardiology. Unidade: FM
Assuntos: ANTICOAGULANTES, FIBRILAÇÃO ATRIAL, ACIDENTE VASCULAR CEREBRAL, AMÉRICA LATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORBALAN, Ramon e NICOLAU, Jose Carlos. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, v. 72, n. 13, p. 1466-1475, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.07.037. Acesso em: 07 nov. 2024.
APA
Corbalan, R., & Nicolau, J. C. (2018). Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, 72( 13), 1466-1475. doi:10.1016/j.jacc.2018.07.037
NLM
Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
Vancouver
Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
Artigo de periodico
Prognostic relevance of appropriate renal function evaluation in pulmonary arterial hypertension (2018)
Alves- Jr., Jose Leonidas; Souza, Rogerio
Fonte: Journal of heart and lung transplantation. Unidade: FM
Assuntos: RIM, HIPERTENSÃO PULMONAR, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES- JR., Jose Leonidas e SOUZA, Rogerio. Prognostic relevance of appropriate renal function evaluation in pulmonary arterial hypertension. Journal of heart and lung transplantation, v. 37, n. 6, p. 692-693, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.healun.2018.02.005. Acesso em: 07 nov. 2024.
APA
Alves- Jr., J. L., & Souza, R. (2018). Prognostic relevance of appropriate renal function evaluation in pulmonary arterial hypertension. Journal of heart and lung transplantation, 37( 6), 692-693. doi:10.1016/j.healun.2018.02.005
NLM
Alves- Jr. JL, Souza R. Prognostic relevance of appropriate renal function evaluation in pulmonary arterial hypertension [Internet]. Journal of heart and lung transplantation. 2018 ; 37( 6): 692-693.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.healun.2018.02.005
Vancouver
Alves- Jr. JL, Souza R. Prognostic relevance of appropriate renal function evaluation in pulmonary arterial hypertension [Internet]. Journal of heart and lung transplantation. 2018 ; 37( 6): 692-693.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.healun.2018.02.005
Artigo de periodico
Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD working group (2018)
Rooij, Daan van; Busatto Filho, Geraldo
Fonte: American journal of psychiatry. Unidade: FM
Assuntos: ADOLESCENTES, CRIANÇAS, HIPOCAMPO, AMÍGDALA DO CEREBELO, IMAGEM POR RESSONÂNCIA MAGNÉTICA, AUTISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROOIJ, Daan van e BUSATTO FILHO, Geraldo. Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD working group. American journal of psychiatry, v. 175, n. 4, p. 359-369, 2018Tradução . . Disponível em: https://doi.org/10.1176/appi.ajp.2017.17010100. Acesso em: 07 nov. 2024.
APA
Rooij, D. van, & Busatto Filho, G. (2018). Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD working group. American journal of psychiatry, 175( 4), 359-369. doi:10.1176/appi.ajp.2017.17010100
NLM
Rooij D van, Busatto Filho G. Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD working group [Internet]. American journal of psychiatry. 2018 ; 175( 4): 359-369.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1176/appi.ajp.2017.17010100
Vancouver
Rooij D van, Busatto Filho G. Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD working group [Internet]. American journal of psychiatry. 2018 ; 175( 4): 359-369.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1176/appi.ajp.2017.17010100
Artigo de periodico-carta/editorial
Building the Future of Trial Design in PAH on Solid Ground (2018)
Souza, Rogerio
Fonte: Chest. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Rogerio. Building the Future of Trial Design in PAH on Solid Ground. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2018.01.041. Acesso em: 07 nov. 2024. , 2018
APA
Souza, R. (2018). Building the Future of Trial Design in PAH on Solid Ground. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.chest.2018.01.041
NLM
Souza R. Building the Future of Trial Design in PAH on Solid Ground [Internet]. Chest. 2018 ; 153( 5): 1089-1090.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.chest.2018.01.041
Vancouver
Souza R. Building the Future of Trial Design in PAH on Solid Ground [Internet]. Chest. 2018 ; 153( 5): 1089-1090.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.chest.2018.01.041
Artigo de periodico
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) (2018)
Giugliano, Robert P.; Nicolau, Jose Carlos
Fonte: Circulation. Unidade: FM
Assuntos: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIUGLIANO, Robert P. e NICOLAU, Jose Carlos. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, v. 137, n. 15, p. 1571-0, 2018Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.117.030950. Acesso em: 07 nov. 2024.
APA
Giugliano, R. P., & Nicolau, J. C. (2018). Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, 137( 15), 1571-0. doi:10.1161/CIRCULATIONAHA.117.030950
NLM
Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950
Vancouver
Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950
Artigo de periodico
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract (2018)
Mach, Francois; Santos, Raul D
Fonte: European heart journal. Unidade: FM
Assuntos: INSUFICIÊNCIA RENAL CRÔNICA, MORTALIDADE, DIABETES MELLITUS, ESTUDOS RANDOMIZADOS, PLACEBOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACH, Francois e SANTOS, Raul D. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. European heart journal, v. 39, n. 27, p. 2526-+, 2018Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehy182. Acesso em: 07 nov. 2024.
APA
Mach, F., & Santos, R. D. (2018). Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. European heart journal, 39( 27), 2526-+. doi:10.1093/eurheartj/ehy182
NLM
Mach F, Santos RD. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract [Internet]. European heart journal. 2018 ; 39( 27): 2526-+.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1093/eurheartj/ehy182
Vancouver
Mach F, Santos RD. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract [Internet]. European heart journal. 2018 ; 39( 27): 2526-+.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1093/eurheartj/ehy182
Artigo de periodico-carta/editorial
Survival of connective tissue disease associated pulmonary arterial hypertension (2018)
Assad, A. P. Luppino; Souza, R.; Oleas, F. Gavilanes; Alves Jr., J. L.; Fernandes, C. J. C. dos Santos; Sampaia-Barros, P. D
Fonte: Clinical and experimental rheumatology. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, TECIDO CONJUNTIVO, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASSAD, A. P. Luppino et al. Survival of connective tissue disease associated pulmonary arterial hypertension. Clinical and experimental rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 07 nov. 2024. , 2018
APA
Assad, A. P. L., Souza, R., Oleas, F. G., Alves Jr., J. L., Fernandes, C. J. C. dos S., & Sampaia-Barros, P. D. (2018). Survival of connective tissue disease associated pulmonary arterial hypertension. Clinical and experimental rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo.
NLM
Assad APL, Souza R, Oleas FG, Alves Jr. JL, Fernandes CJC dos S, Sampaia-Barros PD. Survival of connective tissue disease associated pulmonary arterial hypertension. Clinical and experimental rheumatology. 2018 ; 36( 4): S186-S186.[citado 2024 nov. 07 ]
Vancouver
Assad APL, Souza R, Oleas FG, Alves Jr. JL, Fernandes CJC dos S, Sampaia-Barros PD. Survival of connective tissue disease associated pulmonary arterial hypertension. Clinical and experimental rheumatology. 2018 ; 36( 4): S186-S186.[citado 2024 nov. 07 ]
Artigo de periodico
Long-term outcomes of elagolix in women with endometriosis (2018)
Surrey, Eric; Taylor, Hugh S; Giudice, Linda; Lessey, Bruce A; Abrao, Mauricio S; Archer, David F; Diamond, Michael P; Johnson, Neil P; Watts, Nelson B; Gallagher, J. Chris
Fonte: Obstetrics and gynecology. Nome do evento: 73rd Scientific Congress and Expo of the American-Society-for-Reproductive-Medicine (ASRM). Unidade: FM
Assuntos: ENDOMETRIOSE, HORMÔNIO LIBERADOR DE GONADOTROFINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SURREY, Eric et al. Long-term outcomes of elagolix in women with endometriosis. Obstetrics and gynecology, v. 132, n. 1, p. 147-160, 2018Tradução . . Disponível em: https://doi.org/10.1097/AOG.0000000000002675. Acesso em: 07 nov. 2024.
APA
Surrey, E., Taylor, H. S., Giudice, L., Lessey, B. A., Abrao, M. S., Archer, D. F., et al. (2018). Long-term outcomes of elagolix in women with endometriosis. Obstetrics and gynecology, 132( 1), 147-160. doi:10.1097/AOG.0000000000002675
NLM
Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC. Long-term outcomes of elagolix in women with endometriosis [Internet]. Obstetrics and gynecology. 2018 ; 132( 1): 147-160.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1097/AOG.0000000000002675
Vancouver
Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC. Long-term outcomes of elagolix in women with endometriosis [Internet]. Obstetrics and gynecology. 2018 ; 132( 1): 147-160.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1097/AOG.0000000000002675
Artigo de periodico-carta/editorial
Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary (2017)
Santos Filho, Raul Dias dos
Fonte: Current opinion in lipidology. Unidade: FM
Assuntos: GENÉTICA MÉDICA, EPIDEMIOLOGIA, BIOLOGIA CELULAR, ESTUDOS RANDOMIZADOS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos. Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary. Current opinion in lipidology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/MOL.0000000000000460. Acesso em: 07 nov. 2024. , 2017
APA
Santos Filho, R. D. dos. (2017). Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary. Current opinion in lipidology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. doi:10.1097/MOL.0000000000000460
NLM
Santos Filho RD dos. Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary [Internet]. Current opinion in lipidology. 2017 ; 28( 6): 522-523.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1097/MOL.0000000000000460
Vancouver
Santos Filho RD dos. Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary [Internet]. Current opinion in lipidology. 2017 ; 28( 6): 522-523.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1097/MOL.0000000000000460

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Assuntos

Título da fonte

Agência de fomento